Lamivudine/raltegravir
Lamivudine/raltegravir is a medication used in the treatment of HIV/AIDS. It is a combination of two antiretroviral drugs, lamivudine and raltegravir, which work together to prevent the virus from replicating in the body.
Composition[edit | edit source]
The medication is composed of two active ingredients: lamivudine and raltegravir. Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), which works by blocking the action of an enzyme called reverse transcriptase, which the virus uses to replicate itself. Raltegravir is an integrase inhibitor, which works by blocking another enzyme that the virus uses to insert its genetic material into the cells it infects.
Uses[edit | edit source]
Lamivudine/raltegravir is used in the treatment of HIV/AIDS. It is typically used in combination with other antiretroviral drugs as part of a regimen known as antiretroviral therapy (ART). This therapy is designed to reduce the amount of virus in the body, slow the progression of the disease, and improve the quality of life of people living with HIV/AIDS.
Side Effects[edit | edit source]
Like all medications, lamivudine/raltegravir can cause side effects. These may include nausea, diarrhea, and headache. In rare cases, it can cause more serious side effects, such as liver problems or a severe skin reaction. Patients should contact their healthcare provider if they experience any unusual or severe side effects.
Interactions[edit | edit source]
Lamivudine/raltegravir can interact with other medications, which can affect how it works or increase the risk of side effects. It is important for patients to tell their healthcare provider about all the medications they are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Precautions[edit | edit source]
Before starting treatment with lamivudine/raltegravir, patients should discuss their medical history with their healthcare provider. This includes any history of liver disease, kidney disease, or other medical conditions. Patients should also inform their healthcare provider if they are pregnant, planning to become pregnant, or breastfeeding.
See Also[edit | edit source]
Lamivudine/raltegravir Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD